US Stock MarketDetailed Quotes

OPRX OptimizeRx

Watchlist

8.630
-0.160-1.82%

Close Mar 21 16:00 ET

8.390
-0.240-2.78%

Post 19:58 ET

159.57MMarket Cap-7.85P/E (TTM)

OptimizeRx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

OptimizeRx Q4 2024 Earnings Date

Currency：USDMar 12, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	30.36M	32.32M	+1.96M
Beat Est.	+7.01%	+13.91%	+6.45%
Net Income	--	-78.00K	--
		+98.12%

Analyst Rating

Buy

Mar 22, 2025

OptimizeRx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 21.197M	--
--	2025/Q1	-- / 18.686M	--
Mar 12, 2025	2024/Q4	32.317M / 30.358M	--
Nov 13, 2024	2024/Q3	21.309M / 24.997M	--
Aug 8, 2024	2024/Q2	18.812M / 20.463M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 21.197M--

--2025/Q1-- / 18.686M--

Mar 12, 20252024/Q432.317M / 30.358M--

Nov 13, 20242024/Q321.309M / 24.997M--

Aug 8, 20242024/Q218.812M / 20.463M--

Unlock Free Earnings Estimates

Open Account

OptimizeRx Earnings Reports

OptimizeRx | 10-K: FY2024 Annual Report

Mar 20 16:46 ET

OptimizeRx | 10-Q: Q3 2024 Earnings Report

Nov 14, 2024 15:37 ET

OptimizeRx | 8-K: OptimizeRx Reports Third Quarter 2024 Financial Results

Nov 13, 2024 16:17 ET

OptimizeRx | 10-Q: Q2 2024 Earnings Report

Aug 15, 2024 16:34 ET

Market Insights

Symbol Mini Chart % Chg

AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS

Halozyme Therapeutics

HALO

+1.31%

Collegium Pharmaceutical

COLL

+0.40%

Unlock the Full List

Analysis

Analyst Rating

Updated: Mar 22, 2025

Buy

Buy
66.67%
Hold
33.33%
Sell
0.00%

Price Target

No Data